Show simple item record

dc.contributor.authorEngh, John
dc.contributor.authorAndersen, Eivind
dc.contributor.authorHolmen, Tom Langerud
dc.contributor.authorMartinsen, Egil Wilhelm
dc.contributor.authorMordal, Jon
dc.contributor.authorMorken, Gunnar
dc.contributor.authorEgeland, Jens
dc.date.accessioned2018-01-03T10:01:37Z
dc.date.available2018-01-03T10:01:37Z
dc.date.created2015-12-15T09:14:11Z
dc.date.issued2015
dc.identifier.issn1745-6215
dc.identifier.urihttp://hdl.handle.net/11250/2474283
dc.description.abstractBackground The focus in recent years on physical inactivity and metabolic disturbances in individuals with schizophrenia raises the question of potential effects of physical activity. Physical activity has shown beneficial effects on cognition in healthy older individuals as well as on symptom severity in depression. However, opinions diverge regarding whether aerobic high-intensity interval training reduces cognition and key symptoms in schizophrenia. The main objective for the trial is to investigate the potential effects of aerobic high-intensity interval training on neurocognitive function and mental symptoms in outpatients with schizophrenia. Methods/Design The trial is designed as a randomized controlled, observer-blinded clinical trial. Patients are randomized to 1 of 2 treatment arms with 12-week duration: aerobic high-intensity interval training or computer gaming skills training. All participants also receive treatment as usual. Primary outcome measure is neurocognitive function. Secondary outcome measures will be positive and negative symptoms, wellbeing, tobacco-smoking patterns and physiological/metabolic parameters. Patient recruitment takes place in catchment area-based outpatient clinics.nb_NO
dc.language.isoengnb_NO
dc.publisherBioMed Centralnb_NO
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleEffects of high-intensity aerobic exercise on psychotic symptoms and neurocognition in outpatients with schizophrenia: study protocol for a randomized controlled trialnb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.source.volume16nb_NO
dc.source.journalTrialsnb_NO
dc.source.issue557nb_NO
dc.identifier.doi10.1186/s13063-015-1094-2
dc.identifier.cristin1300719
dc.description.localcode© 2015 Engh et al. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/)nb_NO
cristin.unitcode194,65,35,0
cristin.unitnameInstitutt for psykisk helse
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal